Spots Global Cancer Trial Database for human papillomavirus (hpv)
Every month we try and update this database with for human papillomavirus (hpv) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention | NCT01588301 | Cervical Cancer Human Papilloma... | Attending for c... Kit for Self-co... | 30 Years - 65 Years | University Hospital, Tours | |
| Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) | NCT03946358 | Squamous Cell C... Anal Canal Canc... Cervical Cancer | Blood sample co... Tumor biopsies CT scan Atezolizumab UCPVax | 18 Years - 75 Years | Centre Hospitalier Universitaire de Besancon | |
| A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome | NCT03087370 | WHIM Syndrome | No intervention | - | X4 Pharmaceuticals | |
| REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | NCT03185013 | Cervical Dyspla... Cervical High G... HSIL | VGX-3100 Placebo Electroporation... | 18 Years - | Inovio Pharmaceuticals | |
| Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) | NCT03946358 | Squamous Cell C... Anal Canal Canc... Cervical Cancer | Blood sample co... Tumor biopsies CT scan Atezolizumab UCPVax | 18 Years - 75 Years | Centre Hospitalier Universitaire de Besancon | |
| Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study | NCT03629886 | Cervical Intrae... | HPV (Types 16, ... | 26 Years - | GlaxoSmithKline | |
| AMG 319 in HPV Positive and Negative HNSCC | NCT02540928 | Human Papilloma... Positive or Neg... | AMG 319 hydrate Placebo | 18 Years - | Cancer Research UK | |
| Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study | NCT03629886 | Cervical Intrae... | HPV (Types 16, ... | 26 Years - | GlaxoSmithKline | |
| Trial23 - A Method Study on Cervical Screening in Women Offered HPV-vaccination as Girls | NCT03049553 | Cervical Intrae... | Cobas HPV-DNA t... | 23 Years - 23 Years | University of Copenhagen | |
| Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia | NCT02328872 | Cancer of the C... Cervical Intrae... | Molecular testi... Liquid Based Cy... | 25 Years - 69 Years | VCS Foundation | |
| Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention | NCT01588301 | Cervical Cancer Human Papilloma... | Attending for c... Kit for Self-co... | 30 Years - 65 Years | University Hospital, Tours | |
| Distribution of Human Papillomavirus (HPV) Genotypes in Patients With Cervical Cancer From Croatia | NCT01385436 | Cervical Cancer | 18 Years - 65 Years | University Hospital for Infectious Diseases, Croatia | ||
| The Effect of Physical Activity and Abstain From Smoking on the Precancerous Lesion | NCT03093623 | Cancer Cervix U... Precancerous Le... Smoking | Physical activi... | 20 Years - 70 Years | Taipei Medical University | |
| Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study | NCT01824537 | Human Papilloma... | HPV vaccine, Ga... Hepatitis A vac... | 18 Years - 45 Years | McGill University | |
| RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC | NCT04849377 | Human Papilloma... Head and Neck S... | RT 50 Gy RT 54 GY RT 60 GY Induction Thera... Carboplatin Cisplatin 200 Cisplatin 240 | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | NCT03185013 | Cervical Dyspla... Cervical High G... HSIL | VGX-3100 Placebo Electroporation... | 18 Years - | Inovio Pharmaceuticals | |
| Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life | NCT01181648 | Squamous Cell C... | questionnaire a... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A New Approach to Cervical Cancer Prevention in Kenya | NCT03942705 | Healthy | 18 Years - 60 Years | Indiana University | ||
| Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers | NCT00925288 | Human Papilloma... | Gardasil | 18 Years - 26 Years | Johns Hopkins Bloomberg School of Public Health | |
| The Effect of Physical Activity and Abstain From Smoking on the Precancerous Lesion | NCT03093623 | Cancer Cervix U... Precancerous Le... Smoking | Physical activi... | 20 Years - 70 Years | Taipei Medical University | |
| Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia | NCT02328872 | Cancer of the C... Cervical Intrae... | Molecular testi... Liquid Based Cy... | 25 Years - 69 Years | VCS Foundation | |
| Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in HIV-positive Patients | NCT02615860 | Anal Intraepith... | Topical 85% tri... Surgical electr... | 18 Years - | University Hospital, Essen | |
| Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031) | NCT01078220 | Human Papilloma... | 9 Years - | Merck Sharp & Dohme LLC | ||
| Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV) | NCT01095198 | Human Papilloma... Cervical Intrae... | offer of vagina... 2nd reminder le... | 35 Years - 69 Years | McMaster University | |
| REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | NCT03721978 | Cervical Dyspla... Cervical High G... HSIL | VGX-3100 Placebo CELLECTRA™-5PSP | 18 Years - | Inovio Pharmaceuticals | |
| Distribution of Human Papillomavirus (HPV) Genotypes in Patients With Cervical Cancer From Croatia | NCT01385436 | Cervical Cancer | 18 Years - 65 Years | University Hospital for Infectious Diseases, Croatia | ||
| New Strategies to Assess Anal Cancer Risk In Women | NCT02873741 | Human Immunodef... Human Papilloma... | Perianal and Di... Cervical Swabs Anal Swabs High Resolution... | 18 Years - | Emory University | |
| Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies | NCT02308241 | Human Papilloma... Recurrent/Metas... | Ribavirin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention | NCT01588301 | Cervical Cancer Human Papilloma... | Attending for c... Kit for Self-co... | 30 Years - 65 Years | University Hospital, Tours |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
